POLYINTERFERENT Trademark

Trademark Overview

On Friday, May 21, 2021, a trademark application was filed for POLYINTERFERENT with the United States Patent and Trademark Office. The USPTO has given the POLYINTERFERENT trademark a serial number of 90726207. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 16, 2024. This trademark is owned by Rucker Capital Advisors LLC. The POLYINTERFERENT trademark is filed in the Pharmaceutical Products category with the following description:

Antibacterial pharmaceuticals; Concentrated saline capsules for sinus and nasal irrigation; Mouthwashes for medical purposes; Nasal cleaning preparations for medical purposes; Nasal rinse; Nasal spray preparations; Nasal sprays for medical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Medicated mouthwash; Medicated anti-cavity mouthwashes; Saline solution for sinus and nasal irrigation
polyinterferent

General Information

Serial Number90726207
Word MarkPOLYINTERFERENT
Filing DateFriday, May 21, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesAntibacterial pharmaceuticals; Concentrated saline capsules for sinus and nasal irrigation; Mouthwashes for medical purposes; Nasal cleaning preparations for medical purposes; Nasal rinse; Nasal spray preparations; Nasal sprays for medical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Medicated mouthwash; Medicated anti-cavity mouthwashes; Saline solution for sinus and nasal irrigation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2021
Primary Code005
First Use Anywhere DateFriday, December 30, 2022
First Use In Commerce DateFriday, December 30, 2022

Trademark Owner History

Party NameRucker Capital Advisors LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPerrineville, NJ 08535
Party NameRucker Capital Advisors LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPerrineville, NJ 08535

Trademark Events

Event DateEvent Description
Tuesday, May 25, 2021NEW APPLICATION ENTERED
Wednesday, August 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 2, 2022ASSIGNED TO EXAMINER
Tuesday, February 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 16, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, November 10, 2022SOU EXTENSION 1 FILED
Monday, December 12, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, December 12, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 16, 2023TEAS STATEMENT OF USE RECEIVED
Monday, January 16, 2023PETITION TO REVIVE-GRANTED
Monday, January 16, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, January 16, 2023USE AMENDMENT FILED
Tuesday, January 17, 2023NOTICE OF REVIVAL - E-MAILED
Monday, March 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 14, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 8, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, April 8, 2023NON-FINAL ACTION E-MAILED
Saturday, April 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 24, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 24, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, August 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 21, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, September 25, 2023ASSIGNED TO PETITION STAFF
Friday, September 29, 2023PETITION GRANTED - RESPONSE RECEIVED
Friday, September 29, 2023NOTICE OF REVIVAL - E-MAILED
Monday, October 2, 2023ASSIGNED TO LIE
Monday, October 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 13, 2023SU - FINAL REFUSAL - WRITTEN
Friday, October 13, 2023FINAL REFUSAL E-MAILED
Friday, October 13, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, November 4, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, November 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 4, 2023SU - ACTION CONTINUING FINAL - WRITTEN
Monday, December 4, 2023CONTINUATION OF FINAL REFUSAL E-MAILED
Monday, December 4, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, January 10, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, January 10, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 16, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords

polyinterferent nasal preparations medical pharmaceutical purposes treatment disorders diseases related system